Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$34,008,139
+$5,248,567 QoQ
Shares Held
135,146
+2.2% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.51%
of 13F equity value
Holder Rank
#451
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Jun 30, 2023CallValue
$1,875
CallShares
500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LEVEL FOUR ADVISORY SERVICES, LLC holds $97,082,688 across 12 Drug Manufacturers - General names. ABBV ranks #1 (35.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
135,146 | $34,008,139 | |
| 2 | JNJ |
Johnson & Johnson
|
65,905 | $16,737,892 | |
| 3 | NVO |
Novo Nordisk A S
|
197,413 | $9,463,979 | |
| 4 | MRK |
Merck & Co., Inc.
|
73,273 | $9,415,580 | |
| 5 | LLY |
ELI LILLY & Co
|
7,377 | $8,848,195 | |
| 6 | AMGN |
Amgen Inc
|
15,638 | $5,662,832 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
31,194 | $3,941,049 | |
| 8 | AZN |
Astrazeneca PLC
|
15,186 | $2,879,569 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $34,008,139 | 135,146 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $28,759,572 | 132,234 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $30,103,329 | 131,749 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $29,895,981 | 129,118 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $24,762,821 | 133,406 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $27,104,554 | 129,365 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $22,594,377 | 127,149 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $26,604,308 | 134,719 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $21,141,555 | 123,260 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $24,555,274 | 134,845 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $20,474,171 | 132,117 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $19,419,983 | 130,283 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,875 | 500 | Call | Sole | 2023-07-10 | |
| 2023-06-30 | $23,725,953 | 176,100 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $35,353,047 | 221,830 | Shares | Sole | 2023-06-05 | |
| 2022-12-31 | $22,485,768 | 139,136 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,866,846 | 95,871 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $15,110,459 | 98,658 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $17,055,268 | 105,208 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $14,047,750 | 103,750 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,176,977 | 75,804 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $10,189,864 | 90,464 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $8,702,727 | 80,417 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $9,199,148 | 85,853 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $8,120,994 | 92,716 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $9,911,467 | 100,952 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $5,238,900 | 68,761 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||